This integrated analysis, linking immune modulation with neuromimicry, offers a novel framework for understanding how BST2 engineers a complex ecosystem conducive to tumor growth, invasion, and immune evasion, thereby positioning it as a compelling therapeutic target. Here, BST2 is linked to neoplasm.